Eli Lilly and Company (NEO:LLY)
Canada
· Delayed Price · Currency is CAD 34.15
+0.53 (1.58%)
Feb 28, 2025, 4:00 PM EST
Eli Lilly and Company Revenue
In the year 2024, Eli Lilly and Company had annual revenue of $45.04B USD with 32.00% growth. Eli Lilly and Company had revenue of $13.53B in the quarter ending December 31, 2024, with 44.68% growth.
Revenue
$45.04B
Revenue Growth
+32.00%
P/S Ratio
n/a
Revenue / Employee
$958.36K
Employees
47,000
Market Cap
1,193.30B CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
| Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
| Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
| Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
| Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.51B |
| Curaleaf Holdings | 1.83B |
| WELL Health Technologies | 957.69M |
| Sienna Senior Living | 893.16M |
| Trulieve Cannabis | 1.71B |
| Cronos Group | 169.23M |
| Extendicare | 1.47B |